These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 804350)

  • 1. Quantitative prediction of drug toxicity in humans from toxicology in small and large animals.
    Goldsmith MA; Slavik M; Carter SK
    Cancer Res; 1975 May; 35(5):1354-64. PubMed ID: 804350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics.
    Newell DR; Burtles SS; Fox BW; Jodrell DI; Connors TA
    Br J Cancer; 1999 Nov; 81(5):760-8. PubMed ID: 10555743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal toxicology for early clinical trials with anticancer agents.
    Rozencweig M; Von Hoff DD; Staquet MJ; Schein PS; Penta JS; Goldin A; Muggia FM; Freireich EJ; DeVita VT
    Cancer Clin Trials; 1981; 4(1):21-8. PubMed ID: 6783332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of preclinical toxicology studies for platinum anticancer drugs.
    Clark DL; Andrews PA; Smith DD; DeGeorge JJ; Justice RL; Beitz JG
    Clin Cancer Res; 1999 May; 5(5):1161-7. PubMed ID: 10353752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of preclinical toxicology to findings in early clinical trials.
    Grieshaber CK; Marsoni S
    Cancer Treat Rep; 1986 Jan; 70(1):65-72. PubMed ID: 3943115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical toxicology studies of 4-ipomeanol: a novel candidate for clinical evaluation in lung cancer.
    Smith AC; Barrett D; Stedham MA; el-Hawari M; Kastello MD; Grieshaber CK; Boyd MR
    Cancer Treat Rep; 1987 Dec; 71(12):1157-64. PubMed ID: 3690525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trials of single agents in adult solid tumours: preclinical and clinical aspects.
    Dodion P; Kenis Y; Staquet M
    Drugs Exp Clin Res; 1986; 12(1-3):23-30. PubMed ID: 3732050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
    Griswold DP; Trader MW; Frei E; Peters WP; Wolpert MK; Laster WR
    Cancer Res; 1987 May; 47(9):2323-7. PubMed ID: 3567926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical toxicologic study of 2,3-dihydro-1H-imidazo[1,2-b] pyrazole (IMPY) in mice, dogs, and monkeys.
    Henry MC; Port CD; Rosen E; Levine BS
    Cancer Treat Rep; 1980; 64(10-11):1031-8. PubMed ID: 7459889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adequacies and inadequacies in assessing murine toxicity data with antineoplastic agents.
    Guarino AM; Rozencweig M; Kline I; Penta JS; Venditti JM; Lloyd HH; Holzworth DA; Muggia FM
    Cancer Res; 1979 Jun; 39(6 Pt 1):2204-10. PubMed ID: 445419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicology of anticancer drugs.
    Guarino AM
    Natl Cancer Inst Monogr; 1977 Mar; (45):49-55. PubMed ID: 412105
    [No Abstract]   [Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical toxicology protocols of the Laboratory of Toxicology.
    Prieur DJ; Young DM; Davis RD; Cooney DA; Guarino AM
    Natl Cancer Inst Monogr; 1977 Mar; (45):159-77. PubMed ID: 412104
    [No Abstract]   [Full Text] [Related]  

  • 15. Preclinical toxicologic evaluation of dianhydrogalactitol in dogs and monkeys.
    Folk RM; Pavkov KL; Thake DC
    Cancer Treat Rep; 1976 Oct; 60(10):1585-9. PubMed ID: 828520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative relationships between toxic doses of antitumor chemotherapeutic agents in animals and man.
    Homan ER
    Cancer Chemother Rep 3; 1972 May; 3(1):13-9. PubMed ID: 4626119
    [No Abstract]   [Full Text] [Related]  

  • 17. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
    Cao S; McGuire JJ; Rustum YM
    Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical toxicologic evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in mice, dogs, and monkeys.
    Henry MC; Port CD; Levine BS
    Cancer Treat Rep; 1980; 64(8-9):855-60. PubMed ID: 6893811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential roles for preclinical pharmacology in phase I clinical trials.
    Collins JM; Zaharko DS; Dedrick RL; Chabner BA
    Cancer Treat Rep; 1986 Jan; 70(1):73-80. PubMed ID: 3753662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Dimethyl Methylphosphonate (CAS No. 756-79-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1987 Nov; 323():1-172. PubMed ID: 12748730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.